The SEER database did not provide sufficient information on systemic therapy, such as CT regimens in patients with IBC, Her2-positive patients treated with or without trastuzumab, and hormone receptor-positive patients treated with or without hormonal therapy. The gene discussed is ERBB2; the disease is inflammatory breast carcinoma.